Add to watchlist

The Cooper Companies, Inc. (COO)

Last Price$91.71.4%

Market Cap$18.6B

#COO Rating

#COO Intrinsic Value

#COO Share Price History

#COO Stock Metrics

#COO Stock Financials

COO Income Statement Metrics

#COO Cash Flow Statement Metrics

#COO Income Statement Overview

#COO Balance Sheet Overview

#COO Stock Ratios

#COO Earnings Surprises

#COO Dividends

#COO Dividend Yield

#COO Dividend Per Share

#Competing with COO

Overview

Ratings

Intrinsic Value

Valuation

Growth

Profitability

Health

Capital allocation

Momentum

Earnings

Dividends

Company name	Market Cap	Quality rating	Intrinsic value	1Y Return	Revenue	Free Cash Flow	Revenue growth	FCF margin	Gross margin	ROIC	Total Debt to Equity
The Cooper Companies, Inc.COO COO	$18.6B	5.8	$92.7 1.2% undervalued	(10.8%)	$3,895.4M	$288.1M	8.4%	7.4%	62.8%	5.9%	32.0%
Intuitive Surgical, Inc.ISRG ISRG	$207.3B	6.9	$106.1 81.3% overvalued	41.5%	$8,352.1M	$1,077.2M	17.2%	12.9%	67.5%	26.8%	0.0%
Becton, Dickinson and CompanyBDX BDX	$66.3B	6.1	$262.7 15.0% undervalued	(1.4%)	$20.6B	$2,936.0M	5.9%	14.2%	59.4%	5.4%	55.9%
Alcon Inc.ALC ALC	$46.6B	6.4	$81.3 13.6% overvalued	9.9%	$9,926.1M	$608.0M	3.6%	6.1%	55.6%	9.1%	23.8%
ResMed Inc.RMD RMD	$34.6B	7.6	$190.6 18.2% overvalued	29.9%	$4,926.8M	$1,388.4M	12.9%	28.2%	57.9%	32.9%	16.0%
Baxter International Inc.BAX BAX	$17.9B	4.7	$52.7 51.1% undervalued	(16.2%)	$12.9B	$566.0M	(14.0%)	4.4%	37.1%	(1.5%)	191.5%
West Pharmaceutical Services, Inc.WST WST	$16.9B	6.1	$152.8 33.0% overvalued	(36.3%)	$2,893.1M	$276.4M	(1.9%)	9.6%	34.6%	18.6%	11.3%
Hologic, Inc.HOLX HOLX	$14.7B	7.3	$131.7 108.2% undervalued	(15.2%)	$4,038.9M	$1,135.5M	1.8%	28.1%	56.2%	13.2%	1.0%
Masimo CorporationMASI MASI	$10.4B	5.2	$139.9 26.6% overvalued	50.3%	$2,094.4M	$145.3M	2.3%	6.9%	48.0%	(14.8%)	69.2%
AptarGroup, Inc.ATR ATR	$9,757.8M	6.5	$174.5 19.0% undervalued	4.2%	$3,582.9M	$349.2M	2.7%	9.7%	48.7%	12.0%	27.7%
Repligen CorporationRGEN RGEN	$8,979.7M	5.9	$29.8 80.8% overvalued	(20.6%)	$616.0M	$131.3M	(8.0%)	21.3%	46.9%	(1.2%)	33.3%